307 related articles for article (PubMed ID: 18705314)
1. Evaluation of tumor markers biochip C12 system in the diagnosis of gastric cancer and the strategies for improvement: analysis of 100 cases.
Chen C; Chen LQ; Chen LD; Yang GL; Li Y
Hepatogastroenterology; 2008; 55(84):991-7. PubMed ID: 18705314
[TBL] [Abstract][Full Text] [Related]
2. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
Chen C; Chen LQ; Yang GL; Li Y
Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
[TBL] [Abstract][Full Text] [Related]
3. Application of C12 multi-tumor marker protein chip in the diagnosis of gastrointestinal cancer: results of 329 surgical patients and suggestions for improvement.
Yang XQ; Yan L; Chen C; Hou JX; Li Y
Hepatogastroenterology; 2009; 56(94-95):1388-94. PubMed ID: 19950797
[TBL] [Abstract][Full Text] [Related]
4. Investigation of serum tumor markers in the diagnosis of gastric cancer.
Fan B; Xiong B
Hepatogastroenterology; 2011; 58(105):239-45. PubMed ID: 21510322
[TBL] [Abstract][Full Text] [Related]
5. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
Koga T; Tokunaga E; Sumiyoshi Y; Oki E; Oda S; Takahashi I; Kakeji Y; Baba H; Maehara Y
Hepatogastroenterology; 2008; 55(84):1131-5. PubMed ID: 18705345
[TBL] [Abstract][Full Text] [Related]
6. Circulating level of hepatocyte growth factor as a useful tumor marker in patients with early-stage gastric carcinoma.
Tanaka K; Miki C; Wakuda R; Kobayashi M; Tonouchi H; Kusunoki M
Scand J Gastroenterol; 2004 Aug; 39(8):754-60. PubMed ID: 15513361
[TBL] [Abstract][Full Text] [Related]
7. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
Choi MG; Noh JH; An JY; Hong SK; Park SB; Baik YH; Kim KM; Sohn TS; Kim S
J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447
[TBL] [Abstract][Full Text] [Related]
8. Mucin-producing gastric cancer: clinicopathological difference between signet ring cell carcinoma and mucinous carcinoma.
Fang WL; Wu CW; Lo SS; Chen JH; Hsieh MC; Shen KH; Li AF; Tai LC; Lui WY
Hepatogastroenterology; 2009; 56(93):1227-31. PubMed ID: 19760976
[TBL] [Abstract][Full Text] [Related]
9. Screening the gastric cancer related tumor markers from multi-tumor markers protein chip with kappa coefficient and cost-effectiveness analysis.
Hou JX; Yang XQ; Chen C; Jiang Q; Yang GL; Li Y
Hepatogastroenterology; 2011; 58(106):632-6. PubMed ID: 21661444
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of REG4 for early diagnosis and prognosis of gastric cancer.
Tao HQ; He XJ; Ma YY; Wang HJ; Xia YJ; Ye ZY; Zhao ZS
Hum Pathol; 2011 Oct; 42(10):1401-9. PubMed ID: 21419474
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China.
Song W; Wu SJ; He YL; Cai SR; Zhang CH; Zhang XH; Zhan WH
Chin Med J (Engl); 2009 Jul; 122(13):1486-91. PubMed ID: 19719934
[TBL] [Abstract][Full Text] [Related]
12. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.
Yu J; Cheng YY; Tao Q; Cheung KF; Lam CN; Geng H; Tian LW; Wong YP; Tong JH; Ying JM; Jin H; To KF; Chan FK; Sung JJ
Gastroenterology; 2009 Feb; 136(2):640-51.e1. PubMed ID: 19084528
[TBL] [Abstract][Full Text] [Related]
13. [Application of multiple tumor markers's protein chip in the screen program of the elderly].
Yan HY; Zhong RH; Li J; Luo XH; Chen R
Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Sep; 32(9):924-6. PubMed ID: 22340884
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for lymph node metastasis in histologically poorly differentiated type early gastric cancer.
Kunisaki C; Takahashi M; Nagahori Y; Fukushima T; Makino H; Takagawa R; Kosaka T; Ono HA; Akiyama H; Moriwaki Y; Nakano A
Endoscopy; 2009 Jun; 41(6):498-503. PubMed ID: 19533552
[TBL] [Abstract][Full Text] [Related]
15. [Usefulness of the tumor markers in the diagnosis of idiopathic deep venous thrombosis associated cancer].
Enguídanos MJ; Todolí JA; Saro E; Salvador G; Villar J; Gómez-Biedma S; Micó L; Calabuig JR
An Med Interna; 2002 Nov; 19(11):561-6. PubMed ID: 12522891
[TBL] [Abstract][Full Text] [Related]
16. A rare case of alpha-fetoprotein-producing early gastric cancer.
Shimoyama S; Nozaki K; Kaminishi M; Motoi N; Murakami T
Hepatogastroenterology; 2001; 48(39):687-91. PubMed ID: 11462904
[TBL] [Abstract][Full Text] [Related]
17. The detection of serum anti-p53 antibodies from patients with gastric carcinoma in China.
Qiu LL; Hua PY; Ye LL; Wang YC; Qiu T; Bao HZ; Wang L
Cancer Detect Prev; 2007; 31(1):45-9. PubMed ID: 17292563
[TBL] [Abstract][Full Text] [Related]
18. [Clinical study on tissue polypeptide antigen (TPA) in gastric cancer].
Kanauchi M; Sawai F; Hirayama T; Yumura F; Kanauchi K; Hamaguchi T; Hara Y; Yoshimura K; Nishiura K; Dohi K
Gan No Rinsho; 1985 Sep; 31(11):1367-71. PubMed ID: 2999464
[TBL] [Abstract][Full Text] [Related]
19. [Gastroscopy plus cytology for the diagnosis of gastric cancer or precancerous diseases--report of 127 cases].
Zhao HY
Zhonghua Zhong Liu Za Zhi; 1986 Mar; 8(2):115-7. PubMed ID: 3021413
[TBL] [Abstract][Full Text] [Related]
20. [Utility of measurement of tumor markers for preoperative staging of gastric cancer].
Yano T; Nakatani K; Watanabe A; Sawada H; Okumura T; Yamada Y; Nakano H
Nihon Geka Gakkai Zasshi; 1993 Sep; 94(9):977-87. PubMed ID: 8246875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
